The Latest Cardiac and Vascular News
OR YEHUDA, Israel, April 2, 2025 /PRNewswire/ — Append Medical, a leader in innovative solutions for Left Atrial Appendage (LAA) occlusion, is proud to announce the appointment of Shlomi Nachman as Chairman of the Board. This strategic move reflects the company’s commitment to advancing…
Funds will be used to complete the development of and support the First-in-Human Study of the Appligator™ for the Prevention of Stroke in Atrial Fibrillation Patients OR YEHUDA, Israel, July 6, 2023 /PRNewswire/ — Append Medical has raised $4.35 million as part of an extended series A Round. Investors include participants from the first tranche of the A […]
Funding Will Support the Company’s First Clinical Trial on its Path to Regulatory Clearance OR YEHUDA, Israel, Aug. 4, 2021 /PRNewswire/ — Append Medical, developer of the first no-implant minimally invasive solution for transcatheter Left Atrial Appendage (LAA) exclusion, today announced the completion of a $7.4 million Series A financing round. The round will enable Append […]
